Robert Karsunky
Robert Karsunky is an angel investor based in Switzerland, investing in Energy, Environment & Mobility; Mobility Tech and Sustainability, 1 tracked investment.
About Robert Karsunky
Robert Karsunky is an angel investor headquartered in Switzerland. We have recorded 1 investment for Robert Karsunky to date.
Sector activity concentrates in Energy, Environment & Mobility; Mobility Tech; Sustainability and Aviation. Coverage extends to 8 sectors in total. Investments are concentrated at Series A.
Cellestia Biotech is a clinical-stage biopharma company focused on developing precision oncology therapies through selective inhibition of transcription factors. Their lead candidate, CB-103, is a first-in-class oral pan-NOTCH inhibitor for treating NOTCH-dependent cancers.
Investment Focus
Investment Thesis
Cellestia Biotech is a clinical-stage biopharma company focused on developing precision oncology therapies through selective inhibition of transcription factors. Their lead candidate, CB-103, is a first-in-class oral pan-NOTCH inhibitor for treating NOTCH-dependent cancers.
Team
Explore Robert Karsunky's full profile on Brouky
Portfolio companies, co-investors, AI match scores, and deal flow signals.
Other Investors in Switzerland
Road Ventures
Consumer, Lifestyle & Services, Industry & Hardware, Commerce & Marketing
RKKVC
Artificial Intelligence & Data, Industry & Hardware, Hardware
Ringier Digital Ventures
Consumer, Lifestyle & Services, Software & Developer Tools, automotive
Richemont
Roche
Healthcare & Life Sciences, Health Data & IT, pharmaceutical-development
Roche Venture Fund
Healthcare & Life Sciences, Personalized Medicine, pharmaceutical-development
Roche Venture Funds offers industry partners
Healthcare & Life Sciences, Health Data & IT, molecular-biology
Roche Ventures
Healthcare & Life Sciences, biotechnology, drug discovery